Dec 31, 2017

United Therapeutics Q4 2017 Earnings Report

Total Revenue
$465M
Previous year: $409M
+13.6%
EPS
$3.89
Previous year: $4.12
-5.6%
Gross Profit
$412M
Previous year: $381M
+8.2%
Cash and Equivalents
$705M
Previous year: $1.02B
-31.1%
Free Cash Flow
-$114M
Previous year: $149M
-176.4%
Total Assets
$2.88B
Previous year: $2.33B
+23.8%

United Therapeutics

United Therapeutics